Circulating tumor cells and their role in prostate cancer

Circulating tumor cells (CTC) have become an important biomarker in patients with advanced prostate cancer. CTC count has been demonstrated to be a prognostic factor for overall survival in patients with metastatic castration-resistant prostate cancer (mCRPC). In localized prostate cancer, a clear c...

Descripción completa

Detalles Bibliográficos
Autores principales: Maas, Moritz, Hegemann, Miriam, Rausch, Steffen, Bedke, Jens, Stenzl, Arnulf, Todenhöfer, Tilman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337952/
https://www.ncbi.nlm.nih.gov/pubmed/28836508
http://dx.doi.org/10.4103/aja.aja_29_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337952/
https://www.ncbi.nlm.nih.gov/pubmed/28836508
http://dx.doi.org/10.4103/aja.aja_29_17

Ejemplares similares